Novel PSMA targeting alpha-emitting radioligand [211At]PSAt-3-Ga inhibits tumor growth and increases survival in a preclinical model of human xenograft prostate cancer

Lars Hvass*, Marius Müller, Vladimir Shalgunov, Anne S Clausen, Christian B M Poulie, Emma Aneheim, Holger J Jensen, Matthias M Herth, Andreas Kjaer

*Corresponding author af dette arbejde
OriginalsprogEngelsk
Artikelnummer34
TidsskriftEJNMMI Research
Vol/bind16
Udgave nummer1
ISSN2191-219X
DOI
StatusUdgivet - 27 jan. 2026

Citationsformater